Bruce Torbett

Prof. Bruce Torbett


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MGMichael J. Giffin
Michael J. Giffin
HHHolly Heaslet
Holly Heaslet
ABAshraf Brik
Ashraf Brik
YLYing-Chuan Lin
Ying-Chuan Lin
GCGabrielle Cauvi
Gabrielle Cauvi
BTBruce Torbett
Bruce Torbett

4 August 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MCMax W. Chang
Max W. Chang
CAChristian Ayeni
Christian Ayeni
SBSebastian Breuer
Sebastian Breuer
BTBruce Torbett
Bruce Torbett
The AutoDock family of software has been widely used in protein-ligand docking research. This study compares AutoDock 4 and AutoDock Vina in the context of virtual screening by using these programs to select compounds active against HIV protease. Both programs were used to rank the members of two chemical libraries, each containing experimentally verified binders to HIV protease. In the case of the NCI Diversity Set II, both AutoDock 4 and Vina were able to select active compounds significantly better than random (AUC = 0.69 and 0.68, respectively; p<0.001). The binding energy predictions were highly correlated in this case, with r = 0.63 and ι = 0.82. For a set of larger, more flexible compounds from the Directory of Universal Decoys, the binding energy predictions were not correlated, and only Vina was able to rank compounds significantly better than random. In ranking smaller molecules with few rotatable bonds, AutoDock 4 and Vina were equally capable, though both exhibited a size-related bias in scoring. However, as Vina executes more quickly and is able to more accurately rank larger molecules, researchers should look to it first when undertaking a virtual screen.

15 February 2000 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
KAKaren L. Anderson
Karen L. Anderson
HPHugh Perkin
Hugh Perkin
CSCharles D. Surh
Charles D. Surh
SVSara Venturini
Sara Venturini
RMRichard A Maki
Richard A Maki
BTBruce Torbett
Bruce Torbett
Dendritic cells (DCs) are a heterogeneous population of cells that are specialized for Ag processing and presentation. These cells are believed to derive from both myeloid- and lymphoid-committed precursors. Normal human PBMC-derived, human CD14+ cell (monocyte)-derived, and mouse hematopoietic progenitor-derived DCs were shown to express the hematopoietic cell-restricted, ets family transcription factor PU.1. These populations represent myeloid progenitor-derived DCs. Hematopoietic progenitor cells from PU.1 gene-disrupted (null) mice were unable to generate MHC class IIhigh, CD11c+ myeloid-derived DCs in vitro. Mouse thymic DCs are proposed to be derived from a committed lymphoid progenitor cell that can give rise to T cells as well as DCs. Previously, we showed that CD4 and CD8 T cells developed in PU.1 null mice in a delayed manner and in reduced number. We examined the thymus of 10- to 12-day-old PU.1 null mice and found no evidence of DEC-205+, MIDC-8+ DCs in this tissue. Our findings indicate that PU.1 regulates the development of both thymic and myeloid progenitor-derived populations of DCs, and expand its known role in hematopoietic development.

1 January 2015 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
HKHyunJun Kang
HyunJun Kang
PMPetra Minder
Petra Minder
MPMi Ae Park
Mi Ae Park
WMWalatta-Tseyon Mesquitta
Walatta-Tseyon Mesquitta
BTBruce Torbett
Bruce Torbett
ISIgor Slukvin
Igor Slukvin
The chemokine (C-C motif) receptor 5 (CCR5) serves as an HIV-1 co-receptor and is essential for cell infection with CCR5-tropic viruses. Loss of functional receptor protects against HIV infection. Here, we report the successful targeting of CCR5 in GFP-marked human induced pluripotent stem cells (iPSCs) using CRISPR/Cas9 with single and dual guide RNAs (gRNAs). Following CRISPER/Cas9-mediated gene editing using a single gRNA, 12.5% of cell colonies demonstrated CCR5 editing, of which 22.2% showed biallelic editing as determined by a Surveyor nuclease assay and direct sequencing. The use of dual gRNAs significantly increased the efficacy of CCR5 editing to 27% with a biallelic gene alteration frequency of 41%. To ensure the homogeneity of gene editing within cells, we used single cell sorting to establish clonal iPSC lines. Single cell-derived iPSC lines with homozygous CCR5 mutations displayed the typical characteristics of pluripotent stem cells and differentiated efficiently into hematopoietic cells, including macrophages. Although macrophages from both wild-type and CCR5-edited iPSCs supported CXCR4-tropic virus replication, macrophages from CCR5-edited iPSCs were uniquely resistant to CCR5-tropic virus challenge. This study demonstrates the feasibility of applying iPSC technology for the study of the role of CCR5 in HIV infection in vitro, and generation of HIV-resistant cells for potential therapeutic applications.

29 March 2012 in Genome Biology
Verified
Journal Article
Open access
PDF file
DYDimas Yusuf
Dimas Yusuf
SBStefanie L Butland
Stefanie L Butland
MSMagdalena I Swanson
Magdalena I Swanson
EBEugene Bolotin
Eugene Bolotin
ATAmy Ticoll
Amy Ticoll
WWWyeth W Wasserman
Wyeth W Wasserman
Here we present the Transcription Factor Encyclopedia (TFe), a new web-based compendium of mini review articles on transcription factors (TFs) that is founded on the principles of open access and collaboration. Our consortium of over 100 researchers has collectively contributed over 130 mini review articles on pertinent human, mouse and rat TFs. Notable features of the TFe website include a high-quality PDF generator and web API for programmatic data retrieval. TFe aims to rapidly educate scientists about the TFs they encounter through the delivery of succinct summaries written and vetted by experts in the field. TFe is available at http://www.cisreg.ca/tfe.

1 July 2011 in Journal of Molecular Biology
Verified
Journal Article
Closed access
MCMax W. Chang
Max W. Chang
BTBruce Torbett
Bruce Torbett